TK
Thomas K Equels bought $3K of AIM stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 20,299 shares of AIM stock worth $3K, per an SEC Form 4 filed Nov 6, 2026.
It was an open-market purchase.
The trade was reported on Nov 6, 2026.
AIM has moved +4.4% since the trade date, from $0.15 to $0.16 (Nov 9, 2026 close).
- Traded
- Nov 6, 2026
- Disclosed
- Nov 6, 2026
- Filing delay
- 0 days
- Price since
- +4.4%
- Role
- CEO & President
- Source
- SEC Form 4